Bayer AG is a life science company with core competencies in the areas of health care and agriculture. With the company's focus completely on the Life Science businesses, a new organizational structure was introduced effective Jan 1, 2016. Bayer Group now comprise exclusively of the Life Science businesses. The company started reporting in three segments ' Pharmaceuticals, Consumer Health and Crop Science ' from the third quarter of 2019. Both Animal Health and Currenta were reported as discontinued operations in the quarter. The company acquired U.S. seed giant Monsanto in June, 2018. With the acquisition, Bayer now has the strongest portfolio of seed and crop protection products for a wide range of crops and indications, the best research and development platform and the leading digital farming business.
| Revenue (Most Recent Fiscal Year) | $50.44B |
| Net Income (Most Recent Fiscal Year) | $-2.76B |
| PE Ratio (Current Year Earnings Estimate) | 5.61 |
| PE Ratio (Trailing 12 Months) | 5.60 |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 0.55 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.79 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 1.85 |
| Pre-Tax Margin (Trailing 12 Months) | -5.01% |
| Net Margin (Trailing 12 Months) | -7.26% |
| Return on Equity (Trailing 12 Months) | 13.81% |
| Return on Assets (Trailing 12 Months) | 4.03% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.19 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.72 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 1.11 |
| Inventory Turnover (Trailing 12 Months) | 1.60 |
| Book Value per Share (Most Recent Fiscal Quarter) | $8.82 |
| Earnings per Share (Most Recent Fiscal Quarter) | $0.65 |
| Earnings per Share (Most Recent Fiscal Year) | $1.37 |
| Diluted Earnings per Share (Trailing 12 Months) | $-0.92 |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Biotechnology |
| Common Shares Outstanding | 3.93B |
| Free Float | -- |
| Market Capitalization | $27.51B |
| Average Volume (Last 20 Days) | 0.78M |
| Beta (Past 60 Months) | 0.84 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | -- |
| Percentage Held By Institutions (Latest 13F Reports) | 0.00% |
| Annual Dividend (Based on Last Quarter) | $0.02 |
| Dividend Yield (Based on Last Quarter) | 0.33% |